Hi, what are you looking for?
– – Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, received a $10 million investment led by Shavit Capital...
Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, announced that the first patient was treated in the company’s Phase...
With $1 billion assets under management, Israeli health-tech venture capital aMoon has raised $660 million in commitments to its second fund aMoon2, making it the largest...
– BioBlast’s share lost 38% of its value, Macrocure 25%, and VBL Therapeutics 18%. – The shares of three Israeli biomedical companies that...
– Investors are already asking questions and taking an interest in the possibility of a postponement until the situation is clarified. – Six Israeli...